C6H5BrN4O2
245.03 g/mol
Pharmaceutical IntermediateWarning
8-bromo-3-methyl-3,7-dihydro-1H-purine-2,6-dione
CAS93703-24-3EC819-117-0
Category
Pharmaceutical Intermediate
Compound Class
Heterocycle
Primary Use
Pharmaceutical Intermediate
This compound is this compound, a brominated purine derivative used as a pharmaceutical intermediate in organic synthesis and manufacturing processes.
Pharmaceutical intermediateBuilding block for linagliptin synthesis
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 93703-24-3
Related Compounds
ReferenceSame Category
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine
CAS937046-98-5
pharmaceutical intermediate
ReferenceSame Category
(E)-N'-(2-cyano-4-(3-(1-hydroxy-2-methylpropan-2-yl)thioureido)phenyl)-N,N-dimethylformimidamide
CAS937263-23-5
pharmaceutical intermediate
ReferenceSame Category
4-((1,2,4)Triazolo(1,5-a)pyrid-7-yloxy)-3-methylaniline
CAS937263-71-3
pharmaceutical intermediate
ReferenceSame Category
5-Chloro-2-fluoropyridine-3-boronic acid
CAS937595-70-5
pharmaceutical intermediate
Safety Reference
Warning
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name
8-bromo-3-methyl-7H-purine-2,6-dione
InChIKey
QTEQVEJOXGBDGI-UHFFFAOYSA-N
SMILES
CN1C2=C(C(=O)NC1=O)NC(=N2)Br
Synonyms (16)
- 3-methyl-8-bromoxanthine
- 8-BROMO-3-METHYL-XANTHINE
- MLS-0463078.0001